Russell Clayton insider trades

Open-market stock purchases and sales by Russell Clayton, Chief Medical Officer at Larimar Therapeutics, Inc, from SEC Form 4 filings since Oct 7, 2011.

Recent trades

DateStockTradeValue
Jan 26, 2026LRMR Larimar Therapeutics, IncBought (not open market)—
Jan 26, 2026LRMR Larimar Therapeutics, IncBought (not open market)—

Companies traded

  • LRMR Larimar Therapeutics, Inc: other filings, last Jan 26, 2026
  • DSCO Discovery Laboratories Inc /de/: other filings, last Mar 6, 2014

Get free alerts when Russell Clayton files a new trade →